Realmoney igmorant stockwhore analyst recommends yet another fraud to avid real money investors.
Way to go Jon D. Markman you ignorant stock whore.
"Harrington said his boss, Treyton L. Thomas, would only let him add to those positions if he could answer the following four questions affirmatively:
read the new SEC charges against Treyton L. Thomas
"SEC Charges Treyton L. Thomas and Pembridge Group, Ltd. With Securities Fraud and Stock Manipulation" sec.gov
and:
FEDS NAB MY$TERY MAN By CHRISTOPHER BYRON
November 3, 2004 -- Mystery hedge-fund financier Treyton L. Thomas — the subject of several articles in The Post last year — was charged yesterday in Boston with securities fraud.
216.239.41.104
SuperModels
3 stocks that put a face on terrorism
Companies specializing in face-recognition software were long on promise and short on returns until Sept. 11 turned them white-hot. The question now is for how long.
By Jon D. Markman
Chasing a story
Story stocks almost always sprout from a news development; they germinate in soil rich with shock and greed. At a time when most people are trying to figure out the what of an unexpected event, a clever cadre of early stock speculators zero in on how to take advantage of it.
During the week following the terror attacks, a team of research analysts and portfolio managers at the Pembridge Group in Boston took on that task by homing in on a battery of defense stocks. Bradford G. Harrington, managing director of the firm’s venture capital fund, told me in an interview that after guessing that the complexion of U.S. security had been permanently changed by the attacks, the firm decided to buy not just the usual suspects among the large Pentagon contractors, but also a variety of small-caps that might offer “parabolic” returns.
Harrington’s team did its research on their Bloomberg machines, via Internet searches and with calls to companies. They knew they didn’t have all the information they might want, but they learned enough to know that major beneficiaries of spending over the next year would be companies focused on aviation security, identity verification, vaccine development and virus therapeutics. By 9:30 a.m. on Sept. 17, Pembridge traders waded into the broad-market turmoil and spent $4 million on a basket of 18 stocks. Two months later, that basket would reportedly be worth $10 million. “We did miss a couple of names, but not many,” Harrington said.
By the end of October, however, Pembridge had decided to pare back on most of its wins. The company specializes in modeling cash flows and doing channel checks and customer surveys, so it sold its speculative biotechs first. Next to go were hardware stocks (e.g. flak-jacket makers) that had low margins and lots of competitors. And that left a handful of small aviation-focused stocks that Harrington could view as if they were private and thus might make sense as a traditional venture-capital investment.
Harrington said his boss, Treyton L. Thomas, would only let him add to those positions if he could answer the following four questions affirmatively:
Do you believe there is credible evidence that the current focus on aviation security measures will be permanent, and not ebb and flow with media headlines?
Do you believe there will be an unprecedented level of data sharing among international, federal, state and local law enforcement agencies?
Do you believe that many of the barriers of adoption to “biometrics” have dissipated since the events of Sept. 11?
Do you believe that the new order in aviation security will shift the emphasis beyond baggage and toward passengers?
After further research led them to answer yes for most of the remaining stocks, Thomas posed two more questions: |
